Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
Lohith Gowda, Mithun Shah, Ifra Badar, et al.
American Journal of Hematology
|
February 19, 2026
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
Hans C Lee, Melody R Becnel, Lei Feng, et al.
Leukemia & Lymphoma
|
July 5, 2017
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center
Ghulam Rehman Mohyuddin, Muhammad Salman Faisal, Talha Badar, et al.
British Journal of Haematology
|
February 26, 2013
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Peter M Voorhees, Robert F Manges, Pieter Sonneveld, et al.
Annals of Hematology
|
March 25, 2017
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma
Muhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani, et al.
Nature Communications
|
August 11, 2024
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
Szymon J Szymura, Lin Wang, Tiantian Zhang, et al.
British Journal of Haematology
|
January 24, 2021
Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies
Elisabet E Manasanch, David Berrios, Eric Fountain, et al.
American Journal of Hematology
|
December 15, 2018
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome
Neeraj Y Saini, Romil D Patel, Ankur Varma, et al.
Blood Advances
|
April 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up
Roger G Owen, Helen McCarthy, Shirley D'Sa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 26, 2015
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation
Ryan W Jacobs, Rima M Saliba, Koji Sasaki, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
Lohith Gowda, Mithun Shah, Ifra Badar, et al.
American Journal of Hematology
|
February 19, 2026
A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
Hans C Lee, Melody R Becnel, Lei Feng, et al.
Leukemia & Lymphoma
|
July 5, 2017
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center
Ghulam Rehman Mohyuddin, Muhammad Salman Faisal, Talha Badar, et al.
British Journal of Haematology
|
February 26, 2013
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Peter M Voorhees, Robert F Manges, Pieter Sonneveld, et al.
Annals of Hematology
|
March 25, 2017
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma
Muhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani, et al.
Nature Communications
|
August 11, 2024
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
Szymon J Szymura, Lin Wang, Tiantian Zhang, et al.
British Journal of Haematology
|
January 24, 2021
Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies
Elisabet E Manasanch, David Berrios, Eric Fountain, et al.
American Journal of Hematology
|
December 15, 2018
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome
Neeraj Y Saini, Romil D Patel, Ankur Varma, et al.
Blood Advances
|
April 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up
Roger G Owen, Helen McCarthy, Shirley D'Sa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 26, 2015
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation
Ryan W Jacobs, Rima M Saliba, Koji Sasaki, et al.
Page
of 12